Clinical Trials
2 trialsNCT01573338 2021-04-08
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)
Bayer
Phase 1/2 Terminated
NCT02161419 2018-06-25
CONCEPT-SCLC
Bayer
Phase 2 Terminated